Atlas Trials

Phase II Study of Ribose, Uridine, and Thymidine for a Complex Syndrome Involving Excessive 5'-Nucleotidase Activity

Clinical trial NCT00004658 · COMPLETED

Trial details

NCT number
NCT00004658
Sponsor
National Center for Research Resources (NCRR)
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
5'-Nucleotidase Syndrome
Start date
1995-03-01

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.